This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Immunocore Limited. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Viren Vinubhai Patel: Innovator in Immunotherapy
Introduction
Viren Vinubhai Patel is a notable inventor based in Abingdon, GB. He has made significant contributions to the field of immunotherapy, particularly in the development of T cell receptors that target specific tumor antigens. His work is crucial in advancing cancer treatment options.
Latest Patents
Viren Patel holds a patent for T cell receptors specific for the NY-ESO-1 tumor antigen-HLA-A*02 complex. This invention relates to T cell receptors (TCRs) that bind the HLA-A*02 restricted peptide SLLMWITQC derived from the cancer antigen NY-ESO-1. The TCRs may include mutations within the alpha and/or beta variable domains compared to a native NY-ESO-1 TCR. These TCRs are particularly suitable for use as novel immunotherapeutic reagents for treating malignant diseases. He has 1 patent to his name.
Career Highlights
Viren Patel is associated with Immunocore Limited, a company that focuses on developing innovative therapies for cancer treatment. His work at Immunocore has positioned him as a key player in the field of immunotherapy.
Collaborations
He has collaborated with notable colleagues, including Fiona Chester and Andrew Alexander Knox, to further advance research and development in immunotherapeutic solutions.
Conclusion
Viren Vinubhai Patel's contributions to immunotherapy through his innovative patents and collaborations highlight his importance in the fight against cancer. His work continues to pave the way for new treatment options that could benefit many patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile